Srikant M. Datar net worth and biography

Srikant Datar Biography and Net Worth

Director of Stryker
Dr. Datar is Dean, Harvard Business School and George F. Baker Professor of Business Administration. He was the Arthur Lowes Dickinson Professor at the Graduate School of Business Administration of Harvard University from 1996 to 2020 and is the former Faculty Chair of the Harvard Innovation Labs and Senior Associate Dean for University Affairs. From 1989 to 1996, he was Edmund W. Littlefield Professor at the Graduate School of Business, Stanford University. Dr. Datar is also a director of Novartis AG, a multinational pharmaceutical and consumer health products company, ICF International, Inc., a management, technology and policy consulting firm, and T-Mobile US, Inc., a provider of wireless voice, messaging and data services.

Dr. Datar has an extensive background in accounting and finance and a variety of other business areas, including performance measurement, design thinking and innovation, and machine learning and artificial intelligence. His strong academic and business background and his experience on the board committees of other companies allow him to make significant contributions to our board. His service on the boards of global companies involved in pharmaceuticals and high tech gives him great insights on assessing our technology and strategies to expand our business globally. 

In 2020, Dr. Datar was recognized by the National Association of Corporate Directors (NACD) as the Public Company Director of the Year.

What is Srikant M. Datar's net worth?

The estimated net worth of Srikant M. Datar is at least $1.98 million as of December 5th, 2022. Dr. Datar owns 7,262 shares of Stryker stock worth more than $1,981,800 as of February 6th. This net worth evaluation does not reflect any other investments that Dr. Datar may own. Learn More about Srikant M. Datar's net worth.

How do I contact Srikant M. Datar?

The corporate mailing address for Dr. Datar and other Stryker executives is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. Stryker can also be reached via phone at (269) 385-2600 and via email at [email protected] Learn More on Srikant M. Datar's contact information.

Has Srikant M. Datar been buying or selling shares of Stryker?

Srikant M. Datar has not been actively trading shares of Stryker over the course of the past ninety days. Most recently, Srikant M. Datar sold 1,000 shares of the business's stock in a transaction on Wednesday, December 7th. The shares were sold at an average price of $240.25, for a transaction totalling $240,250.00. Following the completion of the sale, the director now directly owns 6,262 shares of the company's stock, valued at $1,504,445.50. Learn More on Srikant M. Datar's trading history.

Who are Stryker's active insiders?

Stryker's insider roster includes Yin Becker (VP), William Berry, Jr. (VP), Glenn Boehnlein (CFO), Srikant Datar (Director), Roch Doliveux (Director), M. Fink (VP), Robert Fletcher (VP), Allan Golston (Director), Kevin Lobo (CEO), Katherine Owen (VP), Bijoy Sagar (VP), Timothy Scannell (COO), and Ronda Stryker (Director). Learn More on Stryker's active insiders.

Are insiders buying or selling shares of Stryker?

In the last year, insiders at the medical technology company sold shares 8 times. They sold a total of 80,079 shares worth more than $19,354,831.95. The most recent insider tranaction occured on January, 11th when VP M Kathryn Fink sold 6,571 shares worth more than $1,693,280.99. Insiders at Stryker own 6.5% of the company. Learn More about insider trades at Stryker.

Information on this page was last updated on 1/11/2023.

Srikant M. Datar Insider Trading History at Stryker

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/7/2022Sell1,000$240.25$240,250.006,262View SEC Filing Icon  
12/5/2022Sell500$238.70$119,350.007,262View SEC Filing Icon  
11/7/2022Sell300$212.36$63,708.004,861View SEC Filing Icon  
11/2/2022Sell600$216.71$130,026.005,161View SEC Filing Icon  
11/11/2021Sell1,000$263.12$263,120.00View SEC Filing Icon  
5/19/2020Sell350$191.20$66,920.0017,226View SEC Filing Icon  
5/8/2020Sell200$194.32$38,864.0017,686View SEC Filing Icon  
5/6/2020Sell200$186.01$37,202.0017,686View SEC Filing Icon  
8/15/2019Sell350$215.00$75,250.006,844View SEC Filing Icon  
See Full Table

Srikant M. Datar Buying and Selling Activity at Stryker

This chart shows Srikant M Datar's buying and selling at Stryker by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Stryker Company Overview

Stryker logo
Stryker Corp. operates as a medical technology company. It operates through the following segments: Orthopaedics & Spine and MedSurg & Neurotechnology. The Orthopaedics & Spine segment provides implants for use in total joint replacements, such as hip, knee, and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that are used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, patient & caregiver safety technologies, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques, products for brain and open skull based surgical procedures, orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products, minimally invasive products fo
Read More

Today's Range

Now: $271.48
Low: $270.74
High: $281.20

50 Day Range

MA: $249.83
Low: $227.20
High: $283.14

2 Week Range

Now: $271.48
Low: $188.84
High: $284.00

Volume

1,789,865 shs

Average Volume

1,551,460 shs

Market Capitalization

$102.74 billion

P/E Ratio

44.00

Dividend Yield

1.06%

Beta

0.93